Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection

Inclusion Criteria: * 18≤Age≤65; * ECOG performance status of 0 or 1; * Pathological diagnosis with Stage IIIA-N2 NSCLC which is clinically resectable and the N2 is diagnosed by either mediastinoscopy,EBUS,PET/CT; * WBC≥4.0×109/l, ANC≥1.5×109/l, PLT≥100.0×109/l, Hb≥90g/l;hepatorenal function is normal; * Without a history of other malignancies before enrollment, except for non-melanoma skin cancer, in situ cervical cancer; * The patient can understand the research and sign the informed consent. Exclusion Criteria: * Female in pregnancy or lactating;Female of childbearing age without contraception; * With acute infection or other serious underlying disease; * With a significant history of neurological of psychiatric disease，including the dementia which may affect the ability to understand and sign the informed consent; * Have received other treatment within the last 30 days before enrollment; * With uncontrollable diabetes(blood glucose is unstable after treatment or FBG≥8mol/L).